Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Keith L Hansen, DO
Family Practice · HAMPTON, IA · NPI 1447350939
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 440 | 109 |
| Levothyroxine Sodium | Levothyroxine Sodium | 439 | 75 |
| Metoprolol Succinate | Metoprolol Succinate | 341 | 81 |
| Gabapentin | Gabapentin | 313 | 57 |
| Furosemide | Furosemide | 212 | 38 |
| Lisinopril | Lisinopril | 212 | 47 |
| Amlodipine Besylate | Amlodipine Besylate | 187 | 49 |
| Potassium Chloride | Potassium Chloride | 185 | 37 |
| Losartan Potassium | Losartan Potassium | 181 | 46 |
| Tamsulosin Hcl | Tamsulosin Hcl | 176 | 41 |
| Trazodone Hcl | Trazodone Hcl | 141 | 29 |
| Pantoprazole Sodium | Pantoprazole Sodium | 128 | 32 |
| Diclofenac Sodium | Diclofenac Sodium | 127 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 123 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 119 | 35 |
| Omeprazole | Omeprazole | 118 | 35 |
| Sertraline Hcl | Sertraline Hcl | 117 | 20 |
| Tramadol Hcl | Tramadol Hcl | 117 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 116 | 41 |
| Alprazolam | Alprazolam | 115 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 114 | 24 |
| Allopurinol | Allopurinol | 107 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 105 | 29 |
| Metformin Hcl | Metformin Hcl | 96 | 25 |
| Montelukast Sodium | Montelukast Sodium | 95 | 17 |
| Eliquis | Apixaban | 92 | 18 |
| Warfarin Sodium | Warfarin Sodium | 92 | 26 |
| Torsemide | Torsemide | 81 | 25 |
| Carvedilol | Carvedilol | 80 | 24 |
| Metformin Hcl Er | Metformin Hcl | 79 | 22 |
| Famotidine | Famotidine | 74 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 71 | 22 |
| Simvastatin | Simvastatin | 70 | 23 |
| Spironolactone | Spironolactone | 69 | 17 |
| Finasteride | Finasteride | 67 | 14 |
| Methylprednisolone | Methylprednisolone | 67 | 59 |
| Lorazepam | Lorazepam | 65 | 21 |
| Azithromycin | Azithromycin | 63 | 53 |
| Duloxetine Hcl | Duloxetine Hcl | 61 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 59 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 58 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 53 | suppressed |
| Jardiance | Empagliflozin | 52 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 51 | 12 |
| Cefdinir | Cefdinir | 49 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 47 | 15 |
| Meloxicam | Meloxicam | 46 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 45 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 45 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 44 | 44 |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 43 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 42 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | 11 |
| Bupropion Xl | Bupropion Hcl | 41 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 41 | 35 |
| Donepezil Hcl | Donepezil Hcl | 40 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 35 | 12 |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 34 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 33 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 33 | 11 |
| Ezetimibe | Ezetimibe | 32 | suppressed |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Aripiprazole | Aripiprazole | 31 | suppressed |
| Latanoprost | Latanoprost | 31 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Ozempic | Semaglutide | 28 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 28 | suppressed |
| Prednisone | Prednisone | 28 | 19 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 27 | 11 |
| Bumetanide | Bumetanide | 27 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Levetiracetam | Levetiracetam | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 24 | suppressed |
| Synthroid | Levothyroxine Sodium | 24 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 21 | suppressed |
| Mirtazapine | Mirtazapine | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | 11 |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Baclofen | Baclofen | 20 | suppressed |
| Glipizide | Glipizide | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Estradiol | Estradiol | 19 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 19 | suppressed |
| Fentanyl | Fentanyl | 18 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Memantine Hcl | Memantine Hcl | 18 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Ibuprofen | Ibuprofen | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 13 |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Sod Sulf-Potass Sulf-Mag Sulf | Sodium, Potassium,mag Sulfates | 12 | 12 |
| Sucralfate | Sucralfate | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Betaxolol Hcl | Betaxolol Hcl | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error